SCHEMBL30930102

SCHEMBL30930102

Cc1cc(N(C)CCN(C)C)c(N)cc1Nc1nccc(-n2c(=O)n(C)c3ccccc32)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 17/20 0.45
LCK P06239 3/20 0.40
MLNR O43193 1/20 0.37
KDM1A O60341 1/20 0.37
ABCB11 O95342 1/20 0.37
ERBB2 P04626 1/20 0.37
INSR P06213 1/20 0.37
CHRM2 P08172 1/20 0.37
HTR1A P08908 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
DRD2 P14416 1/20 0.37
NQO2 P16083 1/20 0.37
ADRA2C P18825 1/20 0.37
DRD1 P21728 1/20 0.37
ERBB3 P21860 1/20 0.37
SLC6A2 P23975 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
ADORA2A P29274 1/20 0.37
SLC6A4 P31645 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21980702 1.00 EGFR (0.45) EGFRLCKMLNRKDM1AABCB11
SCHEMBL18387041 0.90 EGFR (0.52) EGFRMLNRKDM1AABCB11ERBB2
SCHEMBL30011736 0.90 EGFR (0.52) EGFRMLNRKDM1AABCB11ERBB2
SCHEMBL30930093 0.89 EGFR (0.40) EGFRMLNRKDM1AABCB11ERBB2
SCHEMBL20357839 0.89 EGFR (0.42) EGFRLCK
SCHEMBL20357838 0.89 EGFR (0.40) EGFRMLNRKDM1AABCB11ERBB2
SCHEMBL20358053 0.87 EGFR (0.45) EGFRMLNRKDM1AABCB11ERBB2
SCHEMBL20358025 0.86 EGFR (0.43) EGFRKDRKCNH2
SCHEMBL21980704 0.85 EGFR (0.45) EGFRLCKMLNRKDM1AABCB11
SCHEMBL29464096 0.84 EGFR (0.65) EGFRMLNRKDM1AABCB11ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345900-B1 2, 4-DI-(NITROGEN CONTAINING GROUP) SUBSTITUTED PYRIMIDINE COMPOUND AND PREPARATION METHOD AND USE THEREOF BEBETTER MED INC (CN) 2024-06-12 EP disclosed